Pediatric cancer gene database (Pedican) Home
Pedican
Pediatric cancer database
General information | Literature | Expression | Regulation | Variant | Interaction

Basic Information

Gene ID

6532

Name

SLC6A4

Synonym

5-HTT|5-HTTLPR|5HTT|HTT|OCD1|SERT|SERT1|hSERT;solute carrier family 6 (neurotransmitter transporter, serotonin), member 4;SLC6A4;solute carrier family 6 (neurotransmitter transporter, serotonin), member 4

Definition

5-hydroxytryptamine transporter|5HT transporter|Na+/Cl- dependent serotonin transporter|sodium-dependent serotonin transporter|solute carrier family 6 member 4

Position

17q11.2

Gene Type

protein-coding

Pathways and Diseases

Pathway

5HT2 type receptor mediated signaling pathway;PANTHER;P04374

Pathway

5HT3 type receptor mediated signaling pathway;PANTHER;P04375

Pathway

5HT1 type receptor mediated signaling pathway;PANTHER;P04373

Pathway

5HT4 type receptor mediated signaling pathway;PANTHER;P04376

Disease

ADHD;GAD

Disease

major depression;GAD

Disease

obsessive-compulsive disorder;GAD

Disease

decision making;GAD

Disease

depression depressive disorder, major;GAD

Disease

aggressive behavior;GAD

Disease

Depression;FunDO

Disease

Hypertension, Pulmonary;FunDO

Disease

personality disorders;GAD

Disease

anorexia nervosa;GAD

Disease

Sudden infant death syndrome;FunDO

Disease

IMMUNE;GAD

Disease

Parkinson's disease;GAD

Disease

depressive disorder, major;GAD

Disease

Colon cancer;FunDO

Disease

mood disorders;GAD

Disease

PSYCH;GAD

Disease

chronic obstructive pulmonary disease;GAD

Disease

personality traits;GAD

Disease

Psychotic disorder;FunDO

Disease

Anxiety-related personality traits;OMIM

Disease

decision-making memory impairment;GAD

Disease

affective disorder;GAD

Disease

chronic fatigue syndrome;GAD

Disease

serotonin;GAD

Disease

major and bipolar depressives;GAD

Disease

brain function;GAD

Disease

mania, antidepressant-induced;GAD

Disease

alcohol use;GAD

Disease

unipolar disorder;GAD

Disease

smoking;GAD

Disease

temporomandibular joint pain;GAD

Disease

substance abuse;GAD

Disease

anxiety disorders;GAD

Disease

Atherosclerosis;FunDO

Disease

Obsessive-compulsive disorder 1;OMIM

Disease

Irritable Bowel Syndrome;GAD

Disease

psychosis, alcoholic;GAD

Disease

Migraine;FunDO

Disease

severe hyperkinetic disorders;GAD

Disease

brain electrical response;GAD

Disease

Ulcerative colitis;FunDO

Disease

bipolar affective disorder;GAD

Disease

Herpes;FunDO

Disease

adverse neonatal outcomes birth weight neuromotor symptoms respiratory distress syndrome, neonatal;GAD

Disease

sleep disorders;GAD

Disease

stroke, ischemic;GAD

Disease

Dermatitis;FunDO

Disease

Sexual Dysfunction, Physiological;GAD

Disease

anxiety-related traits;GAD

Disease

bipolar and unipolar disorder;GAD

Disease

eating disorder;GAD

Disease

Drug abuse;FunDO

Disease

Panic disorder;FunDO

Disease

psychoses;GAD

Disease

suicide;GAD

Disease

anxiety disorder migraine;GAD

Disease

suicide family history;GAD

Disease

attention deficit hyperactivity disorder;GAD

Disease

Bipolar disorder;FunDO

Disease

harm avoidance behaviour in an elderly population.;GAD

Disease

Anxiety and hostility and depression;GAD

Disease

schizophrenia;GAD

Disease

chronic obstructive pulmonary disease/COPD;GAD

Disease

Obsessive-compulsive disorder;FunDO

Disease

body mass bulimia harm avoidance personality disorders;GAD

Disease

Autism;GAD

Disease

bipolar disorder;GAD

Disease

anxiety-related temperament and behavior problems;GAD

Disease

aggression;GAD

Disease

mood response;GAD

Disease

Pervasive development disorder;FunDO

Disease

AGING;GAD

Disease

loudness dependence;GAD

Disease

auditory evoked potential;GAD

Disease

conduct disorder;GAD

Disease

violent suicidal behavior;GAD

Disease

Chronic fatigue syndrome;FunDO

Disease

alcohol abuse;GAD

Disease

PHARMACOGENOMIC;GAD

Disease

panic disorder;GAD

Disease

anxiety symptoms;GAD

Disease

METABOLIC;GAD

Disease

alcoholism;GAD

Disease

Autistic disorder;FunDO

Disease

diabetes, type 2;GAD

Disease

pathological gambling;GAD

Disease

CARDIOVASCULAR;GAD

Disease

cardiovascular;GAD

Disease

Generalized anxiety disorder;FunDO

Disease

Fibromyalgia;FunDO

Disease

anorexia nervosa and food intake;GAD

Disease

illegal drug use;GAD

Disease

Chronic obstructive airway disease;FunDO

Disease

REPRODUCTION;GAD

Disease

impulse control disorder;GAD

Disease

alcohol abuse substance abuse;GAD

Disease

Obesity;FunDO

Disease

Anorexia nervosa;FunDO

Disease

alcohol intake;GAD

Disease

Anxiety traits;GAD

Disease

migraine with aura;GAD

Disease

anxiety disorder;GAD

Disease

Neurotic disorder;FunDO

Disease

introversion and neuroticism;GAD

Disease

depression;GAD

Disease

Congenital heart disease;FunDO

Disease

obesity;GAD

Disease

delirium tremens;GAD

Disease

migraine;GAD

Disease

gastrointestinal disorders;GAD

Disease

schizotypal traits;GAD

Disease

SIDS/sudden infant death syndrome;GAD

Disease

Dementia;GAD

Disease

Depression, Postpartum;GAD

Disease

obsessive compulsive disorder;GAD

Disease

hyperkinetic disorder;GAD

Disease

Pulmonary hypertension;FunDO

Disease

Stroke;FunDO

Disease

cognitive ability;GAD

Disease

Epilepsy;FunDO

Disease

dance performance;GAD

Disease

suicide, alcohol-dependent;GAD

Disease

agreeableness;GAD

Disease

CHEMDEPENDENCY;GAD

Disease

neuroticism;GAD

Disease

Behavior disease;FunDO

Disease

Myocardial Infarction;GAD

Disease

Weight Loss;GAD

Disease

NEUROLOGICAL;GAD

Disease

citalopram adverse effects depressive disorder, major;GAD

Disease

attention-deficit hyperactivity disorder;GAD

Disease

Heart failure;FunDO

Disease

affective psychoses;GAD

Disease

auditory-evoked potentials;GAD

Disease

Fibromyalgia;GAD

Disease

violent suicide;GAD

Disease

suicidal behavior;GAD

Disease

mood disorder;GAD

External Links

Links to Entrez Gene

6532

Links to all GeneRIF Items

6532

Links to iHOP

6532

Sequence Information

Nucleotide Sequence

>6532 : length: 1893
atggagacgacgcccttgaattctcagaagcagctatcagcgtgtgaagatggagaagat
tgtcaggaaaacggagttctacagaaggttgttcccaccccaggggacaaagtggagtcc
gggcaaatatccaatgggtactcagcagttccaagtcctggtgcgggagatgacacacgg
cactctatcccagcgaccaccaccaccctagtggctgagcttcatcaaggggaacgggag
acctggggcaagaaggtggatttccttctctcagtgattggctatgctgtggacctgggc
aatgtctggcgcttcccctacatatgttaccagaatggagggggggcattcctcctcccc
tacaccatcatggccatttttgggggaatcccgctcttttacatggagctcgcactggga
cagtaccaccgaaatggatgcatttcaatatggaggaaaatctgcccgattttcaaaggg
attggttatgccatctgcatcattgccttttacattgcttcctactacaacaccatcatg
gcctgggcgctatactacctcatctcctccttcacggaccagctgccctggaccagctgc
aagaactcctggaacactggcaactgcaccaattacttctccgaggacaacatcacctgg
accctccattccacgtcccctgctgaagaattttacacgcgccacgtcctgcagatccac
cggtctaaggggctccaggacctggggggcatcagctggcagctggccctctgcatcatg
ctgatcttcactgttatctacttcagcatctggaaaggcgtcaagacctctggcaaggtg
gtgtgggtgacagccaccttcccttatatcatcctttctgtcctgctggtgaggggtgcc
accctccctggagcctggaggggtgttctcttctacttgaaacccaattggcagaaactc
ctggagacaggggtgtggatagatgcagccgctcagatcttcttctctcttggtccgggc
tttggggtcctgctggcttttgctagctacaacaagttcaacaacaactgctaccaagat
gccctggtgaccagcgtggtgaactgcatgacgagcttcgtttcgggatttgtcatcttc
acagtgctcggttacatggctgagatgaggaatgaagatgtgtctgaggtggccaaagac
gcaggtcccagcctcctcttcatcacgtatgcagaagcgatagccaacatgccagcgtcc
actttctttgccatcatcttctttctgatgttaatcacgctgggcttggacagcacgttt
gcaggcttggagggggtgatcacggctgtgctggatgagttcccacacgtctgggccaag
cgccgggagcggttcgtgctcgccgtggtcatcacctgcttctttggatccctggtcacc
ctgacttttggaggggcctacgtggtgaagctgctggaggagtatgccacggggcccgca
gtgctcactgtcgcgctgatcgaagcagtcgctgtgtcttggttctatggcatcactcag
ttctgcagggacgtgaaggaaatgctcggcttcagcccggggtggttctggaggatctgc
tgggtggccatcagccctctgtttctcctgttcatcatttgcagttttctgatgagcccg
ccacaactacgacttttccaatataattatccttactggagtatcatcttgggttactgc
ataggaacctcatctttcatttgcatccccacatatatagcttatcggttgatcatcact
ccagggacatttaaagagcgtattattaaaagtattaccccagaaacaccaacagaaatt
ccttgtggggacatccgcttgaatgctgtgtaa

Protein Sequence

>6532 : length: 630
METTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAVPSPGAGDDTR
HSIPATTTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLP
YTIMAIFGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIM
AWALYYLISSFTDQLPWTSCKNSWNTGNCTNYFSEDNITWTLHSTSPAEEFYTRHVLQIH
RSKGLQDLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGA
TLPGAWRGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQD
ALVTSVVNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPAS
TFFAIIFFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVT
LTFGGAYVVKLLEEYATGPAVLTVALIEAVAVSWFYGITQFCRDVKEMLGFSPGWFWRIC
WVAISPLFLLFIICSFLMSPPQLRLFQYNYPYWSIILGYCIGTSSFICIPTYIAYRLIIT
PGTFKERIIKSITPETPTEIPCGDIRLNAV



')